Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Resource Pharmaceutical, also known as Ningbo Ziyuan Pharmaceutical, is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of steroid hormones and related active pharmaceutical ingredients (APIs). The company operates high-standard GMP facilities and is a significant supplier of corticosteroid and progestogen intermediates and finished products to both domestic and international markets. Their portfolio includes a wide range of steroid-based medications used in treating inflammatory diseases, endocrine disorders, and reproductive health. By focusing on chemical synthesis and advanced fermentation technologies, they have established themselves as a key player in the global steroid hormone supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Ziyuan Pharmaceutical.